trending Market Intelligence /marketintelligence/en/news-insights/trending/7r7yo7wuhxg1f-pbgwnokg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

OrganiGram recalls medical marijuana lots infected with unapproved pesticide

Mobile Payment Apps Driving Fintech Frenzy In India

Street Talk Episode 42: Banks losing consumer deposits to fintech, digital platforms, commercial might be next

Corporate Renewables Market Looks To Continue Growth After Record 2018

Reframing The Conversation Around Cyber Risk


OrganiGram recalls medical marijuana lots infected with unapproved pesticide

OrganiGram Holdings Inc. is voluntarily recalling certain lots of medical marijuana that were supplied between August and December.

The action follows the detection of amounts of an unapproved pesticide not registered for use on marijuana under the Pest Control Products Act.

The source of the substance is unknown to OrganiGram as the company does not use compounds of this nature in its production processes.

OrganiGram is working with Health Canada officials to determine how the substance came into contact with the marijuana.

Currently, the number of lots affected is small, but additional screening might lead to additional lots being deemed compromised. The company said its operating revenue could be negatively affected if the number of contaminated lots increases significantly.